Chikara Shinohara

2.1k total citations
18 papers, 543 citations indexed

About

Chikara Shinohara is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Chikara Shinohara has authored 18 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Pharmacology and 4 papers in Organic Chemistry. Recurrent topics in Chikara Shinohara's work include Cholesterol and Lipid Metabolism (4 papers), Protease and Inhibitor Mechanisms (4 papers) and Oral and gingival health research (3 papers). Chikara Shinohara is often cited by papers focused on Cholesterol and Lipid Metabolism (4 papers), Protease and Inhibitor Mechanisms (4 papers) and Oral and gingival health research (3 papers). Chikara Shinohara collaborates with scholars based in Japan and United States. Chikara Shinohara's co-authors include Keiji Hasumi, Akira Endo, Kaoru Sakai, Je‐Tae Woo, Tomoko Tsuji, Akira Endo, Daisuke Uemura, Kiyotake Suenaga, Yoshio Takei and Toshihiro Chikanishi and has published in prestigious journals such as FEBS Letters, European Journal of Biochemistry and Tetrahedron.

In The Last Decade

Chikara Shinohara

18 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chikara Shinohara Japan 15 273 136 133 61 57 18 543
Jianying Luo China 15 282 1.0× 132 1.0× 83 0.6× 72 1.2× 55 1.0× 31 517
Marc Van Damme Belgium 8 186 0.7× 78 0.6× 67 0.5× 41 0.7× 47 0.8× 22 452
Teruaki Katayama Japan 13 319 1.2× 259 1.9× 93 0.7× 29 0.5× 30 0.5× 18 682
Tatsuhiko Yoshida Japan 10 597 2.2× 133 1.0× 151 1.1× 44 0.7× 52 0.9× 14 871
Shun‐ichi Ohba Japan 14 305 1.1× 112 0.8× 113 0.8× 61 1.0× 80 1.4× 38 545
Morita Iwami Japan 18 453 1.7× 213 1.6× 257 1.9× 136 2.2× 22 0.4× 31 825
Chunwei Cheng China 15 299 1.1× 70 0.5× 151 1.1× 100 1.6× 41 0.7× 19 633
Siegfried B. Christensen United States 15 435 1.6× 217 1.6× 169 1.3× 37 0.6× 25 0.4× 17 791
Ryuichiro Nakai Japan 13 370 1.4× 119 0.9× 177 1.3× 128 2.1× 44 0.8× 25 606
L. Hunt Switzerland 4 282 1.0× 102 0.8× 29 0.2× 51 0.8× 82 1.4× 5 465

Countries citing papers authored by Chikara Shinohara

Since Specialization
Citations

This map shows the geographic impact of Chikara Shinohara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chikara Shinohara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chikara Shinohara more than expected).

Fields of papers citing papers by Chikara Shinohara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chikara Shinohara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chikara Shinohara. The network helps show where Chikara Shinohara may publish in the future.

Co-authorship network of co-authors of Chikara Shinohara

This figure shows the co-authorship network connecting the top 25 collaborators of Chikara Shinohara. A scholar is included among the top collaborators of Chikara Shinohara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chikara Shinohara. Chikara Shinohara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Okuda, Kazuhiro, Manabu Momose, Masashi Murata, et al.. (2004). Treatment of chronic desquamative gingivitis using tissue-engineered human cultured gingival epithelial sheets: a case report.. PubMed. 24(2). 119–25. 15 indexed citations
2.
Momose, Manabu, et al.. (2002). Vascular Endothelial Growth Factor and Transforming Growth Factor‐α and ‐β1 Are Released From Human Cultured Gingival Epithelial Sheets. Journal of Periodontology. 73(7). 748–753. 22 indexed citations
3.
Suenaga, Kiyotake, et al.. (2000). Structures of Amamistatins A and B, Novel Growth Inhibitors of Human Tumor Cell Lines from Nocardia asteroides. Tetrahedron. 56(35). 6435–6440. 26 indexed citations
4.
Shinohara, Chikara, et al.. (2000). Enhancement of Fibrinolytic Activity of Vascular Endothelial Cells by Chaetoglobosin A, Crinipellin B, Geodin and Triticone B.. The Journal of Antibiotics. 53(3). 262–268. 38 indexed citations
5.
Shinohara, Chikara, et al.. (1999). Arg-Gingipain Inhibition and Anti-bacterial Activity Selective forPorphyromonas gingivalisby Malabaricone C. Bioscience Biotechnology and Biochemistry. 63(8). 1475–1477. 26 indexed citations
6.
Yamaguchi, Kohji, et al.. (1999). (2E,6R)-8-Hydroxy-2,6-dimethyl-2-octenoic Acid, a NovelAnti-osteoporotic Monoterpene, Isolated fromCistanche salsa. Bioscience Biotechnology and Biochemistry. 63(4). 731–735. 33 indexed citations
7.
Chikanishi, Toshihiro, Chikara Shinohara, Tadashi Kikuchi, Akira Endo, & Keiji Hasumi. (1999). Inhibition of Plasminogen Activator Inhibitor-1 by 11-Keto-9(E),12(E)-octadecadienoic Acid, a Novel Fatty Acid Produced by Trichoderma sp.. The Journal of Antibiotics. 52(9). 797–802. 7 indexed citations
8.
Shinohara, Chikara, et al.. (1999). 11-Keto-9(E),12(E)-octadecadienoic Acid, a Novel Fatty Acid that Enhances Fibrinolytic Activity of Endothelial Cells.. The Journal of Antibiotics. 52(2). 171–174. 2 indexed citations
9.
Suenaga, Kiyotake, et al.. (1999). Structures of amamistatins A and B, novel growth inhibitors of human tumor cell lines from an actinomycete. Tetrahedron Letters. 40(10). 1945–1948. 29 indexed citations
10.
11.
Shinohara, Chikara, et al.. (1996). Staplabin, a Novel Fungal Triprenyl Phenol which Stimulates the Binding of Plasminogen to Fibrin and U937 Cell.. The Journal of Antibiotics. 49(10). 961–966. 49 indexed citations
12.
Shinohara, Chikara, Keiji Hasumi, Yoshio Takei, & Akira Endo. (1994). Gypsetin, a new inhibitor of acyl-CoA: cholesterol acyltransferase produced by Nannizzia gypsea var. incurvata IFO 9228. I. Fermentation, isolation, physico-chemical properties and biological activity.. The Journal of Antibiotics. 47(2). 163–167. 29 indexed citations
13.
Nuber, Bernhard, Fritz Hansske, Chikara Shinohara, et al.. (1994). Gypsetin, a new inhibitor of acyl-CoA: cholesterol acyltransferase produced by Nannizzia gypsea var. incurvata IFO 9228. II. Structure determination.. The Journal of Antibiotics. 47(2). 168–172. 19 indexed citations
14.
Hasumi, Keiji, et al.. (1993). Lateritin, a new inhibitor of acyl-CoA: cholesterol acyltransferase produced by Gibberella lateritium IFO 7188.. The Journal of Antibiotics. 46(12). 1782–1787. 26 indexed citations
15.
Shinohara, Chikara, Keiji Hasumi, & Akira Endo. (1993). Inhibition of oxidized low-density lipoprotein metabolism in macrophage J774 by helvolic acid. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1167(3). 303–306. 9 indexed citations
16.
Woo, Je‐Tae, Chikara Shinohara, Kaoru Sakai, Keiji Hasumi, & Akira Endo. (1992). Isolation, characterization and biological activities of concanamycins as inhibitors of lysosomal acidification.. The Journal of Antibiotics. 45(7). 1108–1116. 81 indexed citations
17.
Woo, Je‐Tae, Chikara Shinohara, Kaoru Sakai, Keiji Hasumi, & Akira Endo. (1992). Inhibition of the acidification of endosomes and lysosomes by the antibiotic concanamycin B in macrophage J774. European Journal of Biochemistry. 207(1). 383–389. 53 indexed citations
18.
Hasumi, Keiji, et al.. (1992). Inhibition of the uptake of oxidized low‐density lipoprotein in macrophage J774 by the antibiotic ikarugamycin. European Journal of Biochemistry. 205(2). 841–846. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026